During the past decade, CRS Clinical Research Services Berlin GmbH conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CRS Clinical Research Services Berlin GmbH" #1 sponsor was "Bayer" with 13 trials, followed by "BioNTech SE" with 2 trials sponsored, "Alzeca Biosciences, Inc." with 1 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored and "EirGenix, Inc." with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CRS Clinical Research Services Berlin GmbH" #1 collaborator was "Orion Corporation, Orion Pharma" with 1 trials as a collaborator, "Pfizer" with 1 trials as a collaborator, "Sacura GmbH" with 1 trials as a collaborator and "pharmtrace klinische Entwicklung GmbH" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "CRS Clinical Research Services Berlin GmbH" are "Endometriosis" (3 trials), "Healthy" (3 trials), "COVID-19" (2 trials), "Clinical Trials, Phase I as Topic" (2 trials) and "SARS-CoV-2 Infection" (2 trials). Many other conditions were trialed in "CRS Clinical Research Services Berlin GmbH" in a lesser frequency.

Most popular intervention types in "CRS Clinical Research Services Berlin GmbH" are "Drug" (18 trials), "Biological" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Itraconazole" (5 trials), "BAY1841788 (ODM-201)" (2 trials), "BAY1902607" (2 trials) and "BNT162b2" (2 trials). Other intervention names were less common.

The vast majority of trials in "CRS Clinical Research Services Berlin GmbH" are 11 trials for "Male" genders, 6 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "CRS Clinical Research Services Berlin GmbH". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in CRS Clinical Research Services Berlin GmbH, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in CRS Clinical Research Services Berlin GmbH, 18 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".